Our study findings coincide with those of a previous exploration that after the exclusion of BRCA1 or BRCA2, the TME correlates with TP53, CDH1, and PTEN mutations, their mutations even revealed a highly or moderately increased risk of breast cancer [20]. This evidence concerns the gene BRCA2 and breast cancer.